Table 1.

Program data and coverage from MDA and fMDA rounds, Southern Province, Zambia, 2014–2016

	Round 1 (December 2014)		Round 2 (February 2015)		Round 3 (October 2015)		Round 4 (February 2016)		Total
	MDA	fMDA	MDA	fMDA	MDA	fMDA	MDA	fMDA	MDA	fMDA
Houses visited*	18,237	17,704	14,584	14,610	17,528	18,004	15,257	16,050	65,040	66,370
DHAp courses administered*	78,591	25,372	56,620	17,092	72,006	14,599	64,285	8,256	271,502	65,319
Adherence to all three DHAp courses (%)†	80.6 (71.7–87.2)	91.4 (86.7–94.7)	84.6 (76.0–90.5)	91.7 (87.4–94.7)	80.6 (71.1–87.6)	95.6 (92.4–97.5)	84.9 (75.4–91.2)	93.3 (88.1–96.4)	82.4 (74.5–88.2)	92.8 (89.9–95.0)
Household coverage (%)‡	79.3 (74.2–8.5)	75.3 (70.3–80.3)	63.4 (59.3–67.6)	62.2 (58.0–66.3)	76.3 (71.3–81.2)	76.6 (71.5–81.2)	66.4 (62.0–70.7)	68.3 (63.8–72.8)	70.6 (65.9–75.3)	71.4 (66.7–76.0)

DHAp = dihydroartemisinin–piperaquine; fMDA = focal MDA; MDA = mass drug administration.

^*Ascertained from program records.

^†Ascertained from household surveys.

^‡Estimated using capture–recapture of household lists from surveys and mass treatment rounds.